🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I/II trial studies the side effects of gene-modified immune cell...
Status
Terminated
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2019-07-03
Trial ID
NCT03747484
Avelumab in combination with talazoparib will be investigated in patients w...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2017-10-19
Trial ID
NCT03330405
Treatments Being Tested
This is a single arm, open-label phase Ib study of combining eribulin mesyl...
Status
Terminated
Location
Univeristy of Iowa Hospital and Clinics
Start Date
2018-06-12
Trial ID
NCT03502681
Treatments Being Tested
To evaluate the safety, efficacy and PK of avelumab in combination with axi...
Status
Completed
Location
Aichi Cancer Center Hospital
Start Date
2017-09-08
Trial ID
NCT03289533
Treatments Being Tested
This study will investigate OC-001 as monotherapy, and in combination with,...
Status
Terminated
Location
Cross Cancer Institute
Start Date
2020-09-24
Trial ID
NCT04260802
Treatments Being Tested
This Phase 1b/2 study will examine the effects of the study drugs, avelumab...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2018-08-15
Trial ID
NCT03637491
Treatments Being Tested
The purpose of this study is to determine the biologically active dose of e...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research
Start Date
2016-12-19
Trial ID
NCT02915523
Treatments Being Tested
This is a phase 1b/2 study to evaluate the safety and efficacy of metronomi...
Status
Withdrawn
Location
Chan Soon-Shiong Institute for Medicine
Start Date
2018-05-25
Trial ID
NCT03563170
This is a Phase 1b/2, open label, multicenter, safety and clinical activity...
Status
Terminated
Location
University of Arizona Cancer Center - North Campus
Start Date
2017-12-21
Trial ID
NCT03317496
The purpose of this study is to evaluate the safety and efficacy of aveluma...
Status
Terminated
Location
Emory University Hospital Midtown
Start Date
2015-12-18
Trial ID
NCT02584634
Treatments Being Tested